Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06239259 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Validity and Reliability of Thai Version Clinical Questionnaire for Diagnosis of Carpal Tunnel Syndrome

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Dec 31, 2025 to Dec 31, 2026
    • Study completion date: Feb 28, 2026 to Dec 31, 2026
    v5
  2. Notable Primary completion date: Dec 31, 2024 to Dec 31, 2025
    • Study completion date: Feb 28, 2025 to Feb 28, 2026
    v4
  3. Minor Re-verified, no change to tracked fieldsv3
  4. Notable Primary endpoints revised (2)
    • Secondary endpoints revised (5)
    • Study title shortened, about 4 words
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Kamath and Stothard clinical questionnaire for diagnosing carpal tunnel syndrome (CTS) is a valid score for diagnosis of CTS. However it haven't been translated in to Thai version and the validity and accuracy of the Thai the Thai version have not been yet verified. The research team recognizes the importance and potential benefits of adapting this assessment for use within the Thai population.Therefore, we aim to conduct this research to translate the questionnaire from the original English to Thai and to assess its validity and reliability for diagnosing patients with Carpal Tunnel Syndrome.
Trial Details
NCT Number NCT06239259
Lead Sponsor Siriraj Hospital
Conditions
(from sponsor)
Carpal Tunnel Syndrome
Related terms Carpal Tunnel Syndrome, Disease
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov